☰

Nanologica

Updating the operating model

Industry
Biotechnology
Public information as of
January 2026

A4BEE prepared this analysis from publicly available sources. It reflects our own reading of Nanologica's published strategy and is not endorsed by, or produced in cooperation with, Nanologica. Company website

Strategic priorities

Nanologica operates across 4 stated priorities, with the most concrete near-term plan anchored on chromatography market leadership.

Positioned as a cost-effective alternative to established players (Kromasil) in the preparative chromatography consumables market, targeting the GLP-1 analogue and insulin purification segments with NLAB Saga media.

The Syntagon acquisition enables end-to-end peptide purification services, combining silica consumables with small-molecule API contract manufacturing to offer customers a "complete workflow" solution.

Achieving stable, high-volume NLAB Saga manufacturing at external UK/Ireland sites through equipment upgrades and process optimization to prevent delivery delays that cost potential revenue.

Challenges we see

  • Operations Manufacturing

    External Manufacturing Process Deviations

    Nanologica relies on contract manufacturers in the UK and Ireland for multi-ton NLAB Saga production, but translation of precise lab-scale protocols to industrial scale has caused repeated process deviations requiring equipment replacement.

    "Parallel flow" deviations at external sites have forced the company to decline larger short-term deals due to inability to guarantee delivery times, directly impacting revenue risk.

  • Digital Integration

    Syntagon Post-Merger IT/OT Integration

    The newly acquired Syntagon facility (45+ employees) operated as a peripheral business unit within Ardena group, meaning its IT systems (ERP, LIMS, MES) must be disentangled and reintegrated into Nanologica's corporate structure.

    Legacy system fragmentation drives a high risk of data integrity issues and production downtime during the digital transition period, threatening the goal of positive cash flow by 2026.

  • Digital Operations

    Joining records across systems

    The Application Development team in Sodertalje performs complex chromatography optimization runs governed by manual processes and siloed data tracking in Excel spreadsheets.

    When successful lab methods are handed off to customers or large-scale factories, critical metadata for GMP compliance is lost or manually re-entered, slowing sales cycles and creating compliance gaps.

  • Operations Manufacturing

    Real-Time Production Visibility Gap

    Nanologica lacks real-time visibility into UK/Ireland contract manufacturing lines, relying on retrospective batch reports to identify process deviations after expensive raw materials have been processed.

    Leadership must physically travel to external sites to speed up troubleshooting, preventing "predictable production" and increasing operational costs while extending time-to-resolution.

  • Compliance Regulatory

    GMP Compliance Data Integrity

    As Nanologica expands into the Chinese insulin market where semaglutide patents expire in 2026, customers require exhaustive batch-to-batch reproducibility data compliant with ALCOA+ principles.

    Reliance on manual documentation in lab-scale operations creates audit risks that could jeopardize multi-million SEK supply agreements or trigger FDA/EMA warning letters.

Opportunities, by urgency and business impact

Each bubble is one opportunity, numbered to match the list below. Further right means it bites sooner; higher means a bigger effect on the business. A bigger bubble means a bigger implementation effort.

Source: A4BEE analysis of public sources

  1. External Production Process Control

    Multi-month delivery delays from process deviations at UK/Ireland contract manufacturing sites have forced Nanologica to decline larger orders, directly impacting revenue growth during the critical GLP-1 market window.

    Remote real-time monitoring and "Golden Batch" comparison capabilities would enable Nanologica's CTO to detect deviations early and provide predictive oversight without constant international travel, achieving "predictable production."

  2. Syntagon Digital Integration

    Syntagon's legacy IT systems from the Ardena group require full disentanglement and reintegration, creating risk of data integrity issues and production downtime that could prevent achieving profitability targets.

    A structured digital maturity audit and containerized infrastructure deployment would provide zero-downtime migration while establishing a unified data architecture for the combined entity's API manufacturing operations.

  3. Application Development Workflow Bottleneck

    The Application Development unit generated only SEK 1M in 2024 despite being the sales engine for chromatography business, constrained by manual processes and Excel-based data tracking.

    Digital lab transformation with unified scientific workspaces would eliminate "Excel Islands," streamline customer workflows, and provide professional-grade data visualization to accelerate enterprise sales cycles.

  4. GMP Compliance Documentation

    Manual documentation practices create ALCOA+ compliance gaps that extend customer validation cycles by 12-24 months and pose regulatory risk in the strictly regulated pharmaceutical manufacturing industry.

    Automated data capture and compliance reporting infrastructure would demonstrate digital robustness to conservative pharma clients, shortening sales cycles and eliminating audit risk.

  5. Inventory and Supply Chain Visibility

    Geopolitical tensions cause longer delivery times for components and chemicals, while production instability requires maintaining SEK 19.3M in finished goods inventory, tying up critical working capital.

    Predictive supply chain analytics and inventory optimization would reduce buffer stock requirements while ensuring reliable component availability, freeing working capital for growth initiatives.

What we'd propose

  • Digital CDMO

    Remote Process Intelligence Platform

    Deploy IIoT gateways and real-time monitoring dashboards for UK/Ireland contract manufacturing sites to provide Nanologica leadership with instant visibility into NLAB Saga production batches and early deviation detection.

    • OT/IT convergence

      Pull sensor and controller data off the line into a shared data plane in real time.

      DETAIL

    • Batch intelligence

      Golden-batch comparison and deviation detection running on the same data plane.

      DETAIL

    • Production release flow

      Closed-loop between QA, MES, and ERP so batch record review and release follow the data, not the paperwork.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.

    We've done this before

    See how we do Digital CDMO
  • Enterprise AI

    Post-Merger Digital Integration Framework

    Conduct digital maturity audit of Syntagon facility and implement containerized infrastructure to ensure smooth IT/OT integration while maintaining production continuity during the post-acquisition transition.

    • Ontology layer

      A shared semantic model so lab, process, and quality data describe the same things the same way.

      DETAIL

    • Predictive models

      Models trained on the historical data plane that flag deviations before they become scrap.

      DETAIL

    • Decision surfaces

      Single pane of glass that surfaces model output to the right role at the right moment.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.

    We've done this before

    See how we do Enterprise AI
  • Digital Lab

    Digital Lab Transformation

    Implement Grafana-based scientific workspaces that unify offline analytical results with online sensor data, transforming the Application Development unit into a high-throughput revenue generator with professional client-facing outputs.

    • Unified data backbone

      Connect instruments and LIMS into a single data spine so QC and CDMO records are queryable across sites.

      DETAIL

    • Paperless workflows

      Move lab execution from paper to instrument-captured records with full audit trail.

      DETAIL

    • Continuous QC release

      Review-by-exception dashboards that flag only the records needing scientist attention.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.

    We've done this before

    See how we do Digital Lab
  • Enterprise AI

    GxP Compliance Automation Platform

    Deploy automated data capture and compliance reporting infrastructure that ensures ALCOA+ adherence, provides audit-ready documentation, and demonstrates regulatory robustness to pharmaceutical customers.

    • Ontology layer

      A shared semantic model so lab, process, and quality data describe the same things the same way.

      DETAIL

    • Predictive models

      Models trained on the historical data plane that flag deviations before they become scrap.

      DETAIL

    • Decision surfaces

      Single pane of glass that surfaces model output to the right role at the right moment.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.

    We've done this before

    See how we do Enterprise AI
  • Enterprise AI

    Supply Chain Analytics and Optimization

    Implement predictive analytics for inventory management and supply chain visibility, reducing working capital tied up in buffer stock while ensuring reliable component and chemical availability during geopolitical uncertainty.

    • Ontology layer

      A shared semantic model so lab, process, and quality data describe the same things the same way.

      DETAIL

    • Predictive models

      Models trained on the historical data plane that flag deviations before they become scrap.

      DETAIL

    • Decision surfaces

      Single pane of glass that surfaces model output to the right role at the right moment.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.

    We've done this before

    See how we do Enterprise AI

Digital maturity: today and target

Scored out of 100 across six dimensions. The target is what Nanologica's own published ambition implies — not a perfect score.

Source: A4BEE analysis of public sources
Process Automation 35 → 75
Manual workflows dominate Application Development; lab-to-production handoffs require manual data re-entry; lack of automated compliance documentation
Data Integration 30 → 80
Severe "Excel Islands" in Sodertalje lab; Syntagon systems isolated from Nanologica; no unified data architecture across entities
Real-Time Visibility 25 → 85
No real-time monitoring of UK/Ireland contract manufacturing; retrospective batch reporting only; leadership requires physical site visits
Predictive Analytics 20 → 70
Reactive deviation detection after batch failure; no predictive maintenance or demand forecasting; limited supply chain visibility
IT/OT Convergence 40 → 80
Syntagon facility requires complete system disentanglement; fragmented protocols between sites; legacy equipment at external manufacturers
Compliance Automation 45 → 85
Manual GMP documentation creates ALCOA+ gaps; validation cycles extended by data integrity concerns; audit risk in lab operations

Check this yourself

Our Service Portal has free self-assessments and market comparisons. These are the ones that line up with what we've read above — no sales call required.

Think we've read this right?

Talk to us

Related reading

This is an independent analysis prepared by A4BEE from publicly available information as of January 2026. It reflects A4BEE's own interpretation and opinion, is not affiliated with, endorsed by, or verified with Nanologica, and may be incomplete or inaccurate. All company names and trademarks are the property of their respective owners. To request a correction or removal, contact [email protected].